Becton Dickinson Thailand (BD Thailand)
Becton Dickinson Thailand (BD Thailand) is the Thai subsidiary of Becton Dickinson and Company (NYSE: BDX), one of the world's largest medical-device and diagnostics companies. BD's Thai operations cover sales and distribution of medical devices across BD Medical (syringes, catheters, infusion systems), BD Diagnostics (blood culture, microbiology, flow cytometry), and BD Life Sciences (research instruments, reagents). Thailand is a significant market for BD given the scale of BDMS, Bumrungrad, BCH, and the public hospital network. BD Thailand operates under Thai FDA Class 2 and Class 3 medical-device registration requirements. The company competes with Abbott, Siemens Healthineers, bioMerieux, and Roche Diagnostics for hospital laboratory and diagnostic contracts.
Profile overview
Becton Dickinson Thailand (BD Thailand) is the Thai subsidiary of Becton Dickinson and Company (NYSE: BDX), one of the world's largest medical-device and diagnostics companies. BD's Thai operations cover sales and distribution of medical devices across BD Medical (syringes, catheters, infusion systems), BD Diagnostics (blood culture, microbiology, flow cytometry), and BD Life Sciences (research instruments, reagents). Thailand is a significant market for BD given the scale of BDMS, Bumrungrad, BCH, and the public hospital network. BD Thailand operates under Thai FDA Class 2 and Class 3 medical-device registration requirements. The company competes with Abbott, Siemens Healthineers, bioMerieux, and Roche Diagnostics for hospital laboratory and diagnostic contracts.
Product segments
BD Medical
Syringes, catheters, infusion systems
BD Medical's syringe and IV catheter products are core consumables in Thai public and private hospitals; estimated annual Thai syringe market is 300-500 million units, with BD holding a significant imported-brand share.
BD Diagnostics
Blood culture, microbiology, flow cytometry
BD's diagnostics instruments are entrenched in Thai hospital laboratories; BD BACTEC blood-culture systems are standard at BDMS, Bumrungrad, and major regional hospital networks.
BD Life Sciences
Research instruments and reagents
BD flow-cytometry instruments and reagents serve Thai medical universities and research hospitals; BOI-supported biomedical research expansion is a growth driver for this segment.
Infection prevention
Closed-system and safety devices
BD's safety-engineered needles and closed IV systems are increasingly required in Thai hospital procurement standards for infection-control compliance, supporting recurring upgrade cycles.
Thailand medical device multinational peer comparison
Selected global medical device companies operating in Thailand, 2024-2025
Becton Dickinson (BD Thailand)
Ticker
NYSE:BDX
Primary segment in Thailand
Syringes, diagnostics, flow cytometry
Thai FDA class
Class 2, Class 3
Abbott Diagnostics Thailand
Ticker
NYSE:ABT
Primary segment in Thailand
Diagnostics, point-of-care
Thai FDA class
Class 2, Class 3
Ticker
DE:SHL
Primary segment in Thailand
Imaging, lab diagnostics
Thai FDA class
Class 2, Class 3
Ticker
TYO:4543
Primary segment in Thailand
Syringes, dialysis, cardiac
Thai FDA class
Class 2, Class 3
Roche Diagnostics Thailand
Ticker
SIX:RO
Primary segment in Thailand
Molecular diagnostics, oncology
Thai FDA class
Class 2, Class 3
| Company | Ticker | Primary segment in Thailand | Thai FDA class |
|---|---|---|---|
| Becton Dickinson (BD Thailand) | NYSE:BDX | Syringes, diagnostics, flow cytometry | Class 2, Class 3 |
| Abbott Diagnostics Thailand | NYSE:ABT | Diagnostics, point-of-care | Class 2, Class 3 |
| Siemens Healthineers Thailand | DE:SHL | Imaging, lab diagnostics | Class 2, Class 3 |
| Terumo Thailand | TYO:4543 | Syringes, dialysis, cardiac | Class 2, Class 3 |
| Roche Diagnostics Thailand | SIX:RO | Molecular diagnostics, oncology | Class 2, Class 3 |
Watchpoints 2025-2026
Procurement
Thai government price negotiations
Thailand's GPO (Government Pharmaceutical Organisation) and National Health Security Office negotiate centrally for hospital consumables; price pressure on imported devices is increasing as Thai generic-device manufacturers gain BOI support.
Localisation
BOI local-content requirements
Thailand's BOI medtech promotion package (2024-2027) incentivises local assembly and manufacturing; BD may face pressure to partially localise production to retain preferred procurement status.
Regulatory
Thai FDA Class 3 review timelines
Thai FDA Class 3 medical-device registration timelines of 12-24 months create barriers for new product launches; BD's existing large registered portfolio is a competitive advantage over new market entrants.
Source-pack context
Becton Dickinson Thailand (BD Thailand) is linked to existing Insight report coverage through tracked source packs. The cited sources provide the current evidence trail for market context, regulatory exposure, operator positioning, or sector structure; exact numeric claims should still be checked against raw snapshots before being surfaced as headline metrics.[, , ]
Deep operating read
Becton Dickinson Thailand (BD Thailand) sits inside the report evidence trail for thailand-thai-medical-device-and-bandage-syringe-export-cluster. The strongest available tracked source pack references include Becton Dickinson Thailand BD US-affiliated; Terumo Thailand medical-device, dialysis; Thai medical-device export Customs / DITP data, so the profile can now explain its role through market structure and source context rather than remaining a stub. This remains source-pack grounded rather than fresh-web grounded; any exact metric should wait for raw snapshot confirmation.[, , , ]
Execution watchpoints
The useful buyer angle is not just who Becton Dickinson Thailand (BD Thailand) is, but where the existing report pack places it in the chain: operator, regulator, platform, buyer, or demand proxy. Watch for source freshness, regulatory changes, market-share claims, and ownership/brand ambiguity before promoting this profile to Gold or adding headline metrics. Until those checks are done, the cited pack supports directional context but not new exact claims.[, , , ]
Related Market profiles
Peers, parents, partners, agencies, and other Medical Devices actors.
Competitor
Sri Trang Gloves
World top-5 medical, exam glove manufacturer; vertically integrated via Sri Trang Agro-Industry parent; FY2024 revenue ~ $782.6M.
Open Market profile →
Competitor
Abbott Thailand
US-parent MNC diagnostics, CGM, nutrition, cardiovascular; FreeStyle Libre anchor; ~6% Thai medical-device market share.
Open Market profile →
Competitor
Bionova Thailand
Thai distributor and representative of in-vitro diagnostic and medical-device products serving hospitals and clinical laboratories across Thailand.
Open Market profile →
Sector peer
Cook Medical Thailand
Thai representative office of Cook Medical (USA), established to serve interventional and minimally invasive device needs of Thai hospitals.
Open Market profile →
Reports featuring this profile
Related Market profiles
competitor
Sri Trang Gloves
World top-5 medical, exam glove manufacturer; vertically integrated via Sri Trang Agro-Industry parent; FY2024 revenue ~THB 27B.
competitor
Abbott Thailand
US-parent MNC diagnostics, CGM, nutrition, cardiovascular; FreeStyle Libre anchor; ~6% Thai medical-device market share.
competitor
Bionova Thailand
Thai distributor and representative of in-vitro diagnostic and medical-device products serving hospitals and clinical laboratories across Thailand.